Ligufalimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ligufalimab, covering 2026-02-27 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN [Phase 3]